World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
92
Citations
29091
World Ranking
625
National Ranking
16

Medicine

D-Index
92
Citations
29468
World Ranking
11357
National Ranking
155

Overview

Pietro Vernazza is affiliated with the University of St. Gallen in Switzerland. Their research work primarily focuses on medicine, with significant contributions in the fields of infectious diseases, virology, epidemiology, pulmonary and respiratory medicine, and hepatology.

The scientist's main research topics include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV/AIDS drug development and treatment
  • SARS-CoV-2 detection and testing
  • Hepatitis C virus research

Pietro Vernazza has published extensively in several scholarly venues, with frequent publications in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Swiss Medical Weekly
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases

Recent scholarly papers associated with their work include:

  • Cohort Profile Update: The Swiss HIV Cohort Study (SHCS), 2021, International Journal of Epidemiology
  • The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS), 2022, Frontiers in Immunology
  • Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies, 2020, Clinical Infectious Diseases
  • A highly virulent variant of HIV-1 circulating in the Netherlands, 2022, Science
  • Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study, 2020, Clinical Chemistry and Laboratory Medicine (CCLM)

The scientist frequently collaborates with several co-authors, including:

  • Christian R. Kahlert
  • Matthias Cavassini
  • Enos Bernasconi
  • Huldrych F. Günthard
  • Roger D. Kouyos

Best Publications

  • Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

    Alison J. Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

    Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti

  • Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

    Myron S Cohen;Irving F Hoffman;Rachel A Royce;Peter Kazembe

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Brief but efficient: acute HIV infection and the sexual transmission of HIV.

    Christopher D. Pilcher;Hsiao Chuan Tien;Joseph J. Eron;Pietro L. Vernazza

  • Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.

    Matthias Egger;Bernard Hirschel;Patrick Francioli;Philippe Sudre

  • Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

    Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

  • Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

    Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer

  • Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

    Gilbert R. Kaufmann;Hansjakob Furrer;Bruno Ledergerber;Luc Perrin

  • Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model.

    Hrishikesh Chakraborty;Pranab K. Sen;Ronald W. Helms;Pietro L. Vernazza

  • HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.

    Andrew N. Phillips;Schlomo Staszewski;Rainer Weber;Ole Kirk

  • Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV

    Pietro L. Vernazza;Luigi Troiani;Markus J. Flepp;Richard W. Cone

  • Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades.

    Jacob Levi;Alice Raymond;Anton Pozniak;Pietro Vernazza

  • Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

    Hansjakob Furrer;Matthias Egger;Milos Opravil;Enos Bernasconi

  • Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

    S Yerly;S Vora;P Rizzardi;J P Chave

  • Characterization of V3 Sequence Heterogeneity in Subtype C Human Immunodeficiency Virus Type 1 Isolates from Malawi: Underrepresentation of X4 Variants

    Li Hua Ping;Julie A.E. Nelson;Irving F. Hoffman;Jody Schock

  • CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1 : results of the staccato randomised trial

    Jintanat Ananworanich;Angèle Gayet-Ageron;Michelle Le Braz;Wisit Prasithsirikul

  • Unsafe Sex and Increased Incidence of Hepatitis C Virus Infection among HIV-Infected Men Who Have Sex with Men: The Swiss HIV Cohort Study

    Andri Rauch;Martin Rickenbach;Rainer Weber;Bernard Hirschel

  • Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.

    Aysel Gueler;André Moser;Alexandra Calmy;Huldrych F. Günthard

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

Frequent Co-Authors

Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Manuel Battegay
Manuel Battegay University Hospital of Basel
Hansjakob Furrer
Hansjakob Furrer University of Bern
Matthias Cavassini
Matthias Cavassini University of Lausanne
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Rainer Weber
Rainer Weber University of Zurich
Sabine Yerly
Sabine Yerly University of Geneva
Bruno Ledergerber
Bruno Ledergerber University of Zurich
Thomas Klimkait
Thomas Klimkait University of Basel
Bernard Hirschel
Bernard Hirschel University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens up diverse career paths in healthcare and research. Many students complement their microbiology knowledge with related fields such as health information management and public health. For those interested in the administrative side of healthcare, pursuing the best online health information management degree cahiim accredited programs offers a practical pathway into managing vital healthcare data efficiently.

If you’re aiming for quicker certification options, consider exploring online medical billing and coding certificate fast programs. These certificates can jumpstart careers in medical administration, often allowing you to work alongside microbiologists and other healthcare professionals.

For those wanting to broaden their qualifications, a variety of online healthcare degrees complement microbiology studies, including nursing, healthcare management, and clinical research degrees, all delivered with flexibility for working students.

Additionally, public health remains a crucial area for microbiology graduates. Looking into the easiest mph online programs to get into can be a strategic step for those aiming to impact health policy and epidemiology without the intense admissions processes of some traditional programs.

Best Scientists Citing Pietro Vernazza

Trending Scientists